Future work

Biomarker, genetic and lipidomics data from LIPID study samples continue to be analysed. In the near future the remaining whole blood and plasma samples form the study will be moved to the NSW Health Statewide Biobank in Sydney. Plans and funding applications for their use in future studies are underway.